# Ryan Specialty Holdings, Inc.: overview

RYAN · NYSE · CIK 1849253 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ryan.md) · [Financials](/companies/ryan/financials.md) · [Filings](/companies/ryan/filings.md) · [Insiders](/companies/ryan/insiders.md)

Latest reported revenue: [$902.7m](/filings/0001849253-26-000036.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001849253-26-000036).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [588](/filings/0001849253-25-000016.md) | [649 d](/filings/0001849253-26-000006.md) | [676](/filings/0001849253-26-000026.md) | [841](/filings/0001849253-26-000036.md) | [740](/filings/0001849253-25-000016.md) | [738 d](/filings/0001849253-26-000006.md) | [783](/filings/0001849253-26-000026.md) | [903](/filings/0001849253-26-000036.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [13.9%](/filings/0001849253-25-000016.md) | [16.8% d](/filings/0001849253-26-000006.md) | [14.8%](/filings/0001849253-26-000026.md) | [22.7%](/filings/0001849253-26-000036.md) | [15.0%](/filings/0001849253-25-000016.md) | [12.4% d](/filings/0001849253-26-000006.md) | [12.1%](/filings/0001849253-26-000026.md) | [20.0%](/filings/0001849253-26-000036.md) |
| Net margin | % | [3.0%](/filings/0001849253-25-000016.md) | [2.1% d](/filings/0001849253-26-000006.md) | [(4.1%)](/filings/0001849253-26-000026.md) | [6.2%](/filings/0001849253-26-000036.md) | [4.2%](/filings/0001849253-25-000016.md) | [1.1% d](/filings/0001849253-26-000006.md) | [2.3%](/filings/0001849253-26-000026.md) | [4.7%](/filings/0001849253-26-000036.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [101 d](/filings/0001849253-25-000016.md) | [260 d](/filings/0001849253-26-000006.md) | [(143)](/filings/0001849253-26-000026.md) | [354 d](/filings/0001849253-26-000036.md) | [167 d](/filings/0001849253-25-000016.md) | [263 d](/filings/0001849253-26-000006.md) | [(167)](/filings/0001849253-26-000026.md) | [291 d](/filings/0001849253-26-000036.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,433](/filings/0000950170-24-021657.md) | [1,712](/filings/0001628280-25-006973.md) | [2,027](/filings/0001849253-26-000006.md) | [2,456](/filings/0001849253-26-000006.md) | [2,995](/filings/0001849253-26-000006.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [13.0%](/filings/0000950170-24-021657.md) | [16.9%](/filings/0001628280-25-006973.md) | [17.7%](/filings/0001849253-26-000006.md) | [17.4%](/filings/0001849253-26-000006.md) | [16.5%](/filings/0001849253-26-000006.md) |
| Net margin | % | [4.6%](/filings/0000950170-24-021657.md) | [3.6%](/filings/0001628280-25-006973.md) | [3.0%](/filings/0001849253-26-000006.md) | [3.9%](/filings/0001849253-26-000006.md) | [2.1%](/filings/0001849253-26-000006.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [(69.7)](/filings/0000950170-24-021657.md) | [328](/filings/0001628280-25-006973.md) | [477](/filings/0001849253-26-000006.md) | [515](/filings/0001849253-26-000006.md) | [641](/filings/0001849253-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ryan/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $396.3m | 10,494,326 |  | Reduced −375,499 |
| [Vulcan Value Partners, LLC](/funds/1556785.md) | 2026-06-30 | $298.8m | 7,912,669 |  | Added +1,317,334 |
| [Orbis Allan Gray Ltd](/funds/1663865.md) | 2026-06-30 | $238.2m | 6,307,845 |  | New +6,307,845 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $210.5m | 5,572,840 |  | Added +2,467,296 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $198.9m | 5,266,873 |  | Reduced −75,394 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $197.0m | 5,218,054 |  | Added +17,262 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $193.7m | 5,130,211 |  | Added +4,803,478 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $139.9m | 3,706,058 |  | Added +72,722 |
| [Polar Capital Holdings Plc](/funds/1837309.md) | 2026-06-30 | $111.0m | 2,940,000 |  | Added +490,000 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $104.5m | 2,767,113 |  | Added +479,238 |

## Recent filings

[All 533 filings](/companies/ryan/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:32 ET | [10-Q](/filings/0001849253-26-000047.md) | Quarterly report, period 2026-09-30 | 0001849253-26-000047 |
| 2026-10-29 | 16:08 ET | [8-K](/filings/0001849253-26-000045.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001849253-26-000045 |
| 2026-08-07 | 16:26 ET | [8-K](/filings/0001849253-26-000040.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001849253-26-000040 |
| 2026-07-31 | 07:32 ET | [10-Q](/filings/0001849253-26-000036.md) | Quarterly report, period 2026-06-30 | 0001849253-26-000036 |
| 2026-07-30 | 16:07 ET | [8-K](/filings/0001849253-26-000034.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001849253-26-000034 |
| 2026-05-26 | 07:15 ET | [8-K](/filings/0001849253-26-000031.md) | 7.01 Regulation FD disclosure | 0001849253-26-000031 |
| 2026-05-01 | 17:06 ET | [8-K](/filings/0001849253-26-000029.md) | 5.07 Shareholder vote results | 0001849253-26-000029 |
| 2026-05-01 | 07:15 ET | [10-Q](/filings/0001849253-26-000026.md) | Quarterly report, period 2026-03-31 | 0001849253-26-000026 |
| 2026-04-30 | 16:08 ET | [8-K](/filings/0001849253-26-000023.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001849253-26-000023 |
| 2026-04-30 | 16:07 ET | [8-K](/filings/0001849253-26-000022.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001849253-26-000022 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001849253-26-000006.md), filed Feb 13, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c47048f1-e640-4dab-b157-33778517bef0)

## About the filer

- CIK: 1849253
- Tickers: RYAN
- Exchange: NYSE
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 07:34 ET. No prices; not investment advice.